Recombinant DLL3 (Rovalpituzumab Biosimilar) antibody

Catalog No. ABIN7597962

This Humanized Chimeric antibody specifically detects DLL3 (Rovalpituzumab Biosimilar) in . It exhibits reactivity toward Human.

Quick Overview for Recombinant DLL3 (Rovalpituzumab Biosimilar) antibody (ABIN7597962)

Target: DLL3 (Rovalpituzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This DLL3 (Rovalpituzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-DLL3 (Rovalpituzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Rovalpituzumab Biosimilar Antibody

Specificity: Drosophila Delta homolog 3, Delta3, Delta-like protein 3, DLL3

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 2.53 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for DLL3 (Rovalpituzumab Biosimilar)

Target: DLL3 (Rovalpituzumab Biosimilar)

Alternative Name: Rovalpituzumab Biosimilar

Target Type: Biosimilar

Background: Drosophila Delta homolog 3, Delta3, Delta-like protein 3, DLL3

UniProt: Q9NYJ7

CAS-No: 1613313-01-1